EGF-depleting vaccine plus nivolumab shows survival signal in advanced NSCLC
A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...
A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...
A newly published protocol details a three-component tumor organoid co-culture system with 3D live-cell imaging that quantifies single-cell dynamics of ...
A new review outlines how lipid-based nanomedicines could deliver pathway-specific siRNA to treat hepatocellular carcinoma, highlighting delivery design, preclinical candidates ...
A new review details how microbiome-derived metabolites such as short-chain fatty acids, secondary bile acids, and tryptophan derivatives regulate host ...
A transcriptomic study links dietary restriction-associated immune and vascular changes in melanoma tumors to better prognosis and improved immunotherapy response.
A benchmark of 438 TCR–pMHC mutations shows experimental structures remain the best input for binding-affinity predictors, while AlphaFold 3 mutant ...
Hyaluronic acid-modified taurine-polydopamine nanoparticles combined photothermal therapy with taurine-driven immune modulation to suppress gastric tumors in mice.
A new review summarizes how CD4+ cytotoxic T cells act as both protective and pathological effectors, and why targeting them ...
A new study reports that lactate in the pancreatic tumor microenvironment promotes metabolic reprogramming and PD-L1 upregulation through the TRMT6-SIRT5 ...
An international team of researchers, including Rutgers microbiologists, has outlined ten priorities in Nature Medicine for testing how the human ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine